Human Genome Epidemiology Literature Finder
Records 1 - 13 (of 13 Records) |
Query Trace: Ovarian Neoplasms and NRAS[original query] |
---|
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Mar 30 (8): 777-82. Janku Filip, Wheler Jennifer J, Westin Shannon N, Moulder Stacy L, Naing Aung, Tsimberidou Apostolia M, Fu Siqing, Falchook Gerald S, Hong David S, Garrido-Laguna Ignacio, Luthra Rajyalakshmi, Lee J Jack, Lu Karen H, Kurzrock Razel |
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma. Virchows Archiv : an international journal of pathology 2014 Aug 465 (2): 193-8. Zannoni Gian Franco, Improta Giuseppina, Chiarello Gaia, Pettinato Angela, Petrillo Marco, Scollo Paolo, Scambia Giovanni, Fraggetta Filip |
Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing. International journal of oncology 2015 Jun 46 (6): 2389-98. Takenaka Masataka, Saito Motonobu, Iwakawa Reika, Yanaihara Nozomu, Saito Misato, Kato Mamoru, Ichikawa Hitoshi, Shibata Tatsuhiro, Yokota Jun, Okamoto Aikou, Kohno Takas |
A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecologic oncology 2016 Apr 141 (1): 108-12. Penson R T, Sales E, Sullivan L, Borger D R, Krasner C N, Goodman A K, Del Carmen M G, Growdon W B, Schorge J O, Boruta D M, Castro C M, Dizon D S, Birrer M |
EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas. Cancer research 2017 Jun . Etemadmoghadam Dariush, Azar Walid J, Lei Ying, Moujaber Tania, Garsed Dale W, Kennedy Catherine, Fereday Sian, Mitchell Chris, Chiew Yoke-Eng, Hendley Joy, Group Australian Ovarian Cancer Study, Sharma Raghwa, Harnett Paul, Li Jason, Christie Elizabeth L, Patch Ann-Marie, George Joshy, Au-Yeung George, Mir Arnau Gisela, Holloway Timothy P, Semple Timothy, Pearson John V, Waddell Nicola, Grimmond Sean, Köbel Martin, Rizos Helen, Lomakin Ivan, Bowtell David D L, DeFazio An |
Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer. Neoplasia (New York, N.Y.) 2019 May 21 (6): 582-590. Van Nieuwenhuysen Els, Busschaert Pieter, Laenen Annouschka, Moerman Philippe, Han Sileny N, Neven Patrick, Lambrechts Diether, Vergote Igna |
Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients. Gynecologic oncology 2019 Feb . Rodriguez-Freixinos V, Lheureux S, Mandilaras V, Clarke B, Dhani N C, Mackay H, Butler M O, Wang L, Siu L L, Kamel-Reid S, Stockley T, Bedard P L, Oza A |
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals. Expert review of molecular diagnostics 2020 12 21 (1): 101-107. Cavic Milena, Krivokuca Ana, Boljevic Ivana, Spasic Jelena, Mihajlovic Milica, Pavlovic Marijana, Damjanovic Ana, Radosavljevic Davorin, Jankovic Radmi |
Therapeutic options for mucinous ovarian carcinoma. Gynecologic oncology 2020 Jan . Gorringe Kylie L, Cheasley Dane, Wakefield Matthew J, Ryland Georgina L, Allan Prue E, Alsop Kathryn, Amarasinghe Kaushalya C, Ananda Sumitra, Bowtell David D L, Christie Michael, Chiew Yoke-Eng, Churchman Michael, DeFazio Anna, Fereday Sian, Gilks C Blake, Gourley Charlie, Hadley Alison M, Hendley Joy, Hunter Sally M, Kaufmann Scott H, Kennedy Catherine J, Köbel Martin, Le Page Cecile, Li Jason, Lupat Richard, McNally Orla M, McAlpine Jessica N, Pyman Jan, Rowley Simone M, Salazar Carolina, Saunders Hugo, Semple Timothy, Stephens Andrew N, Thio Niko, Torres Michelle C, Traficante Nadia, Zethoven Magnus, Antill Yoland C, Campbell Ian G, Scott Clare |
Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report. Case reports in women's health 2022 2 34 e00395. Silva R, Moran B, Das S, Mulligan N, Doughty M, Treacy A, Sheahan K, Kelly C M, Duffy A G, Perry A S, Brennan D |
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. Journal of translational medicine 2022 12 20 (1): 606. Wong Kwong-Kwok, Bateman Nicholas W, Ng Chun Wai, Tsang Yvonne T M, Sun Charlotte S, Celestino Joseph, Nguyen Tri V, Malpica Anais, Hillman R Tyler, Zhang Jianhua, Futreal P Andrew, Rojas Christine, Conrads Kelly A, Hood Brian L, Dalgard Clifton L, Wilkerson Matthew D, Phippen Neil T, Conrads Thomas P, Maxwell George L, Sood Anil K, Gershenson David |
Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome. Gynecologic oncology 2023 5 174 157-166. John P Thomson, Robert L Hollis, Juliette van Baal, Narthana Ilenkovan, Michael Churchman, Koen van de Vijver, Frederike Dijk, Alison M Meynert, Clare Bartos, Tzyvia Rye, Ian Croy, Patricia Diana, Mignon van Gent, Helen Creedon, Rachel Nirsimloo, Fiona Nussey, Christianne Lok, C Simon Herrington, Charlie Gourl |
Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma. Scientific reports 2023 5 13 (1): 7681. Robert L Hollis, John P Thomson, Juliette van Baal, Narthana Ilenkovan, Michael Churchman, Koen van de Vijver, Frederike Dijk, Alison M Meynert, Clare Bartos, Tzyvia Rye, Ian Croy, Patricia Diana, Mignon van Gent, Helen Creedon, Rachel Nirsimloo, Christianne Lok, Charlie Gourley, C Simon Herringt |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: